Conference table



We Deliver Unparalleled Expertise 

Biologics Consulting Group, Inc. is the leading regulatory consulting firm in product development and regulatory strategy for Biologics, Drugs, and Medical Devices. For over 20 years, Biologics Consulting Group has supported clients in the preparation and review of CBER, CDER and CDRH regulatory applications, product development strategies, Quality (or CMC) requirements, pre-clinical and clinical study designs, GLP/GCP/GMP audits, and strategic business planning.



pieGraphicToday’s Challenges Are Tomorrow’s Opportunities

Biologics Consulting Group, Inc. advises a global client base in navigating the dynamic areas of product development and regulatory strategy. We have knowledge and contemporary experience with regulatory pathways and can provide the requisite preclinical, clinical, quality, analytical, manufacturing support to increase your chances for success.



Our Difference is Our Consultants

The Biologics Consulting Group team is comprised of over 40 consultants with experience as FDA reviewers and senior supervisors, certified FDA inspectors, and senior leaders from the biotechnology industry. Our team brings unparalleled expertise in FDA regulations, with over 20 consultants having prior positions in the Agency and nearly constant contact with multiple review divisions at CBER, CDER, and CDRH. Our understanding of the FDA enables us to bridge the tough decisions to find the right balance of business, scientific, and regulatory in product development.





Speaker: Nanda Subbarao, Ph.D.

subbarao_photo Dr. Subbarao has expertise in anyaltic CMC technical and regulatory requirements and R&D/GMP quality systems for drugs and neuroceuticals.
October 28, 2015
Orlando, FL

American Association of Pharmaceutical Scientists-Annual Meeting

  Session Title: Essentials of Stability Testing for Pharmaceutical Scientists: A Live Session of Stability Testing 101 E-Learning Course
November 17, 2015
Somerset, NJ

2015 Eastern Anaylitcal Symposium and Exposition

  Session Title: Lifecycle Management of Analytical Validation of Pharmaceutical Products
December 1, 2015
Bethesda, MD

2015 PDA/FDA Vaccines Conference

  Session Title: Analytical Methods for Vaccines

Speaker: Norman Baylor, Ph.D.

baylor_photo Dr. Baylor has expertise in global public health and developing regulatory strategies for vaccines and related products.
November 2-4, 2015

Vaccines R&D- 2015

  Session Title: Regulatory Perspective on the Evaluation of New Vaccine Technologies

Speaker: Michael Trapani, MS, MBA

trapani_photo Mr. Trapani specializes in regulatory affairs, regulatory compliance and quality assurance.
October 27, 2015
Baltimore, MD


RAPS 2015 Regulatory Convergence Meeting

  Session Tittle: Your Company has Received a Warning Letter from the FDA... Now What?!

Benjamin Del Tito, Jr., Ph.D.

deltito_photo Dr. Del Tito has expertise in quality and regulatory affairs for control of vaccines, biopharmaceuticals and pharmaceutical products.
November 3, 2015
1:30 pm ET

Live Audio -- Audio Educator, Knowledge for Healthcare

  Session Title: Control for Starting Materials for Biologics Products -- Why is this Critical?


400 N. Washington Street, Suite 100, Alexandria, Virginia 22314
Toll: 1 (703) 739-5695 . US Toll Free: 1 (800) 485-0106 . Fax: 1 (703) 548-7457